OncoZenge AB
ONCOZ | FN
Overview
Corporate Details
- ISIN(s):
- SE0015504097
- LEI:
- 2549003980RBCR6NIF38
- Country:
- Sweden
- Address:
- Gustavslundsvagen 34, 5 tr, 167 51 Bromma
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
OncoZenge AB focuses on developing treatments for oral pain caused by cancer therapies. Their solutions aim to improve patient quality of life.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-07 | Stian Kildal | Other | Buy | 20,439 | 85,026.24 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
KANABO GROUP PLC | United Kingdom | KNB | |
|
Karo Pharma AB | Sweden | KARO | |
|
Kinarus Therapeutics Holding AG | Switzerland | KNRS | |
|
Klaria Pharma Holding AB | Sweden | KLAR | |
|
Kolinpharma | Italy | KIP | |
|
Krka | Slovenia | KRKG | |
|
Kyivmedpreparat | Ukraine | KMED | |
|
Labiana S.A. | Spain | LAB | |
|
Labocanna Spolka Akcyjna | Poland | LCN | |
|
Laboratorio Farmaceutico Erfo | Italy | ERFO |